Addendum: Sustained response of three pediatric BRAFV600E mutated high-grade gliomas to combined BRAF and MEK inhibitor therapy.

Toll, Stephanie A; Tran, Hung N; Cotter, Jennifer; Judkins, Alexander R; Tamrazi, Benita; Biegel, Jaclyn A; Dhall, Girish; Robison, Nathan J; Waters, Kaaren; Patel, Palak; Cooper, Robert; Margol, Ashley S.

Afiliação

Toll SA; Division of Hematology, Oncology and Blood and Marrow Transplantation, Children's Center for Cancer and Blood Diseases, Children's Hospital Los Angeles, Los Angeles, CA, USA.
Tran HN; University of Southern California Keck School of Medicine, Los Angeles, CA, USA.
Cotter J; Kaiser Permanente Southern California, Los Angeles, CA, USA.
Judkins AR; University of Southern California Keck School of Medicine, Los Angeles, CA, USA.
Tamrazi B; Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, CA, USA.
Biegel JA; University of Southern California Keck School of Medicine, Los Angeles, CA, USA.
Dhall G; Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, CA, USA.
Robison NJ; University of Southern California Keck School of Medicine, Los Angeles, CA, USA.
Waters K; Department of Radiology and Imaging, Children's Hospital Los Angeles, Los Angeles, CA, USA.
Patel P; University of Southern California Keck School of Medicine, Los Angeles, CA, USA.
Cooper R; Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, CA, USA.
Margol AS; Division of Hematology, Oncology and Blood and Marrow Transplantation, Children's Center for Cancer and Blood Diseases, Children's Hospital Los Angeles, Los Angeles, CA, USA.

Oncotarget ; 14: 502, 2023 May 19.

Article em En | MEDLINE | ID: mdl-37204254

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article